BlackRock Investment Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

BlackRock Investment Management’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$18K	Hold	3,494	–	–	﹤0.01%	3423
2016 Q3	$16K	Hold	3,494	–	–	﹤0.01%	3433
2016 Q2	$14K	Sell	3,494 -388	-10%	-$1.45K	﹤0.01%	3507
2016 Q1	$12K	Hold	3,882	–	–	﹤0.01%	3565
2015 Q4	$18K	Hold	3,882	–	–	﹤0.01%	3479
2015 Q3	$18K	Buy	3,882 +168	+5%	+$1.08K	﹤0.01%	3484
2015 Q2	$27K	Sell	3,714 -72,502	-95%	-$545K	﹤0.01%	3369
2015 Q1	$646K	Buy	76,216 +603	+0.8%	+$5.14K	﹤0.01%	2818
2014 Q4	$704K	Buy	75,613 +102	+0.1%	+$887	﹤0.01%	2792
2014 Q3	$629K	Buy	75,511 +1,988	+3%	+$18.4K	﹤0.01%	2838
2014 Q2	$850K	Buy	73,523 +5,135	+8%	+$52.7K	﹤0.01%	2722
2014 Q1	$867K	Buy	68,388 +21,901	+47%	+$283K	﹤0.01%	2615
2013 Q4	$503K	Sell	46,487 -1,281	-3%	-$14.9K	﹤0.01%	2948
2013 Q3	$591K	Buy	47,768 +1,346	+3%	+$18.6K	﹤0.01%	2818
2013 Q2	$620K	Buy	+46,422	New	+$597K	﹤0.01%	2709

Other funds holding DSCI

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BlackRock Investment Management's DSCI Position: Q4 2016 in Review

BlackRock Investment Management held its Derma Sciences, Inc. Common Stock (DE) (DSCI) position steady in Q4 2016 at 3,494 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #3423.

BlackRock Investment Management first reported a position in DSCI in Q2 2013 and has held it in 15 quarters since. The position peaked at $867K in Q1 2014. 52 funds tracked by Wall St. Rank hold DSCI as of Q4 2016.

BlackRock Investment Management held 3,494 shares of Derma Sciences, Inc. Common Stock (DE) worth $18K as of Q4 2016.
BlackRock Investment Management left its Derma Sciences, Inc. Common Stock (DE) share count unchanged in Q4 2016.
Derma Sciences, Inc. Common Stock (DE) made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3423 holding.
BlackRock Investment Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $867K in Q1 2014.
52 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.